In patients with axial spondyloarthritis (axSpA), chronic back pain typically manifests itself for the first time before the age of 45. Timely referral to rheumatology specialists and close monitoring of symptoms in patients already diagnosed with axSpA help to ensure that patients achieve adequate disease control. Although NSAIDs are still considered first-line therapy, there are now several highly effective treatment alternatives for patients who do not respond adequately.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Biologics for plaque psoriasis
What increases the chance of a sustained remission?
- Pain and autism
Hurdles to pain treatment for autistic patients
- Findings from the ALS Symposium 2024 in Montreal
Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
- Long-COVID
Increased risk with asthma and COPD
- Atopic dermatitis in children
New secondary analysis on dietary interventions
- Case report: bronchobiliary fistula
Disguised as pneumonia
- Rehospitalization risk for cardiopulmonary diseases
Transition to the outpatient setting is crucial
- Telemonitoring